Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
GE
GE HealthCare Technologies Inc. Common Stock
GEHC
Mkt Cap
$31.43B
Volume
2.20M
Next Earnings
October 28th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
GE
GEHC
GE
GE HealthCare Technologies Inc. Common Stock
GEHC
News
·
Vaso Stock Surges 149% in a Year: What's Behind the Rally?
Mkt Cap
$31.78B
Volume
2.20M
Next Earnings
October 28th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
Vaso Stock Surges 149% in a Year: What's Behind the Rally?
Vaso Corporation (VASO) has gained 149% over the past year, significantly outperforming its industry peers and the S&P 500. The healthcare-focused company reported improved Q2 2026 results with higher revenues and profitability, driven by growth in professional sales services and medical device segments. Following the divestiture of its IT services business, VASO is streamlining operations and strengthening its focus on healthcare. However, the company faces challenges including heavy dependence on GE HealthCare and ongoing profitability pressures in its proprietary medical products division.
Zacks Investment Research · Oct 16, 2026
ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?
Intuitive Surgical (ISRG) is expected to report Q3 2026 earnings on October 20 with EPS projected at $2.61 (up 8.75%) and revenue growth of 15% to $2.88B. While the company benefits from international procedure growth and strong da Vinci 5 demand, it faces headwinds from moderating U.S. procedure growth, China pricing pressures, and higher costs. The stock trades at a premium valuation of 35.87X forward P/E, leaving limited room for disappointment.
Zacks Investment Research · Oct 16, 2026
Digital X-ray Market - Global and Regional Analysis and Forecast, 2026-2036 | Mobile Imaging, AI Workflows, and Detector Innovation Drive Growth to $9.90 Billion
The global digital X-ray market is projected to grow from $5.79 billion in 2025 to $9.90 billion by 2036, expanding at a 5.09% CAGR. Growth is driven by the transition from analog to digital systems, adoption of mobile and retrofit solutions, AI-enabled workflows, and detector innovations. North America leads the market, while Asia-Pacific presents significant expansion opportunities. Key challenges include workforce shortages and integration complexity.
GlobeNewswire Inc. · Oct 16, 2026
Global Mobile X-ray Systems Market Analysis and Forecast, 2026-2036 | AI-Enabled Digital Imaging and Asia-Pacific Growth Drive a $4.00 Billion Market by 2036
The global mobile X-ray systems market is projected to grow from $2.06 billion in 2025 to $4.00 billion by 2036, with a CAGR of 6.30%. Growth is driven by rising chronic disease prevalence, increasing hospitalization rates, and demand for point-of-care imaging. Digital systems dominate with 91.57% market share, while handheld/ultra-portable systems are the fastest-growing segment. Asia-Pacific leads regional growth at 7.43% CAGR, followed by North America and Europe.
GlobeNewswire Inc. · Oct 16, 2026
Global Mobile C-Arm Market Analysis and Forecast, 2026-2036 | Market to Reach $3.71 Billion as Minimally Invasive Surgery, AI, and 3D Imaging Drive 5.35% CAGR
The global mobile C-arm market is projected to grow from $2.09 billion in 2025 to $3.71 billion by 2036, expanding at a 5.35% CAGR. Growth is driven by rising adoption of minimally invasive surgery, AI integration, 3D imaging, and aging populations. North America leads the market, with hospitals as the primary end-users. Key challenges include high capital costs and shortage of skilled professionals, while advanced storage and archiving capabilities present significant growth opportunities.
GlobeNewswire Inc. · Oct 16, 2026
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz is investigating GE HealthCare Technologies for potential federal securities law violations. The investigation follows the company's April 2026 earnings report, which revealed a PDx supplier recall that impacted profit performance and margins, leading to reduced full-year EPS guidance and a 13.2% stock price decline. The company's CFO also stepped down in July 2026.
GlobeNewswire Inc. · Oct 2, 2026
GEHC vs. SYK: Which Stock Should Value Investors Buy Now?
In a comparison of two medical products stocks, GE HealthCare Technologies (GEHC) emerges as the more attractive option for value investors compared to Stryker (SYK). GEHC has a higher Zacks Rank (#2 Buy vs #3 Hold), lower forward P/E ratio (12.97 vs 18.23), and a lower P/B ratio (2.63 vs 4.36), earning a Value grade of B compared to SYK's C grade.
Zacks Investment Research · Oct 2, 2026
GE HealthCare (GEHC) Upgraded to Buy: Here's Why
GE HealthCare Technologies (GEHC) received an upgrade to Zacks Rank #2 (Buy) based on upward trends in earnings estimates. The company is expected to earn $4.93 per share for fiscal year 2026, with analysts steadily raising estimates over the past three months. The upgrade positions GEHC in the top 20% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals.
Zacks Investment Research · Sep 30, 2026
Software as a Medical Device Market Set for Rapid Growth Through 2034 as AI Innovation, Digital Health Adoption, and Regulatory Advances Reshape the Competitive Landscape
The global Software as a Medical Device (SaMD) market is projected to grow from USD 2.10 billion in 2025 to USD 8.90 billion by 2034, expanding at a CAGR of 17.4%. Growth is driven by AI-enabled diagnostics, digital therapeutics, cloud-based deployment, and maturing regulatory pathways. Diagnostic and screening software leads with 42% market share, while radiology applications dominate at 34%. North America holds 45% of the market, with Asia-Pacific expected to record the fastest growth.
GlobeNewswire Inc. · Sep 17, 2026
Ultrasound AI Market Size to Surge to USD 22.03 Billion by 2035 at a CAGR of 26.62% – SNS Insider
The global Ultrasound AI market is projected to grow from USD 2.09 billion in 2025 to USD 22.03 billion by 2035, with a CAGR of 26.62%. Growth is driven by deep learning advancements, point-of-care imaging adoption, and sonographer shortages. North America leads with 45.54% market share, while Asia-Pacific shows the fastest growth at 28.57% CAGR. Hardware dominates at 48% market share, with software as the fastest-growing segment.
GlobeNewswire Inc. · Sep 17, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
GE
GEHC
GE HealthCare Technologies Inc. Common Stock
Buy
Sell
Market
Limit
Soon
GEHC
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any GEHC yet.
Related Tickers
PH
PHG
—
Earnings
Dividends
Ex Oct 23
Amount
$0.0400
Pays
Nov 13
Last · Jul 24
Quarterly
Amount
$0.0350
Yield
0.20%
Annual
$0.14